Paliperidone Tablet, Film Coated, Extended Release
Product Images NDC 47335-765
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Paliperidone (NDC 47335-765). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Spl-paliperidone3mg (Spl Paliperidone3mg)
The text provides instructions for the usage of Paliperidone extended-release tablets. It is recommended to swallow the tablets whole and not to crush or chew them. The tablets are meant to be taken once daily and the package contains 30 tablets. This is a prescription drug, as indicated by "Rx only" on the label.*
Spl-paliperidone6mg (Spl Paliperidone6mg)
This is a medication label for Paliperidone Extended-Release Tablets. The tablets should be taken orally and swallowed whole. They should not be divided, crushed, or chewed. The recommended dosage is once daily. The label also includes the drug's National Drug Code (NDC) and prescription information.*
Spl-paliperidone9mg (Spl Paliperidone9mg)
Structure (Structure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.